3621 results for «484»
3621 results
Rapid-fire abstracts: Session 11
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: the impact of cerebral embolic protection devices on acute ischaemic stroke complicating TAVI, TTVR clinical results prediction based on surgical risk scores, effects of tricuspid transcatheter edge-to-edge repair on tricuspid annular diameter, and much more!
Rapid-fire clinical cases: Session 6
29 Nov 2022 – From PCR London Valves 2022
Discover a selection of abstracts presented during PCR LV 2022: valve-in-valve implant in a dysfunctional tricuspid bioprosthesis, first patient in TRICURE FIH trial, challenging percutaneous closure of prosthetic paravalvular leaks, and more!
TAVI challenges: session 4
29 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.
Rapid-fire clinical cases: Session 7
29 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: simultaneous transcatheter edge-to-edge repair of mitral and tricuspid valve, transcatheter valve implantation in mitral and tricuspid valve position, TEER failure in mitral and tricuspid position: troubleshooting approach for a rare but still eventful case,...
Primary mitral regurgitation: treatment options when the anatomy is simple
27 Nov 2022 – From PCR London Valves 2022
Consult this session to learn about the different technical aspects and limitations for both surgical and catheter-based techniques and to understand the design and implications of two current RCTs comparing interventional and surgical techniques in patients with primary mitral regurgitation.
Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?
29 Nov 2022 – From PCR London Valves 2022
Watch these presentations to better understand what's happening in the field of tricuspid valve intervention and to appreciate the characteristics of current and newly emerging transcatheter devices.
Challenging TAVI cases
18 May 2021 – From EuroPCR 2021
In this session, look at TAVR complications, study how to find a way to deliver an aortic valve prosthesis, and think about how to treat a failing tissue AVR in a fit 60 year-old doctor.
Dealing with shock
18 May 2021 – From EuroPCR 2021
Find out more about left main shock syndrome, always an unpredictable situation, and study the case of a STEMI patient with cardiogenic shock.
Challenging heart failure and mitral regurgitation cases
18 May 2021 – From EuroPCR 2021
In this session, analyze the cases of a young patient with multivessel coronary disease and severe heart failure, and a patient with heart failure, prior rigid mitral ring replacement, and severe mitral regurgitation.
Mitral valve challenges
18 May 2021 – From EuroPCR 2021
Watch this session to find out more about flail bioprosthetic mitral valve treatment, acute prosthetic mitral valve regurgitation, severe structural and non-structural mitral bioprosthesis degeneration, and severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement
Uncrossable lesions
18 May 2021 – From EuroPCR 2021
Thanks to this session, get to know how to treat an uncrossable lesion, and especially in patients with inferior STEMI.
Surgery or PCI?
18 May 2021 – From EuroPCR 2021
In this session, discover a case when the surgeon ́s ambitions are higher than his courage.
Which way to choose?
18 May 2021 – From EuroPCR 2021
Watch this video to check whether you would have opted for the same vessel and the same strategy when facing this NSTEMI case.
Emergency cases in the cathlab: there is not just ACS and PCI
18 May 2021 – From EuroPCR 2021
Look at this video presenting a patient with massive bilateral central pulmonary embolism: how would you treat?
Sailing in between the devil and the deep blue sea
18 May 2021 – From EuroPCR 2021
In this session, conduct a reflection on dislodged stents and the best way to deal with such a problem.
Treating complex coronary lesions: right case right time Prevail™ DCB
01 Oct 2021 – From AICT-AsiaPCR 2021
Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...
Telescope guide extension catheter in complex coronary interventions
01 Oct 2021 – From AICT-AsiaPCR 2021
View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.
Renal denervation in the real-world: performance in high risk subgroups
05 Oct 2021 – From AICT-AsiaPCR 2021
After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...
Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients
06 Oct 2021 – From AICT-AsiaPCR 2021
In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...
